Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 17/20 | 0.86 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.82 |
| ▸ | BRD1 | O95696 | 1/20 | 0.82 |
| ▸ | CCL2 | P13500 | 1/20 | 0.82 |
| ▸ | TAF1 | P21675 | 1/20 | 0.82 |
| ▸ | BRD2 | P25440 | 1/20 | 0.82 |
| ▸ | SMARCA2 | P51531 | 1/20 | 0.82 |
| ▸ | SMARCA4 | P51532 | 1/20 | 0.82 |
| ▸ | BRPF1 | P55201 | 1/20 | 0.82 |
| ▸ | EP300 | Q09472 | 1/20 | 0.82 |
| ▸ | BPTF | Q12830 | 1/20 | 0.82 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.82 |
| ▸ | BRD3 | Q15059 | 1/20 | 0.82 |
| ▸ | BRDT | Q58F21 | 1/20 | 0.82 |
| ▸ | ATAD2 | Q6PL18 | 1/20 | 0.82 |
| ▸ | PBRM1 | Q86U86 | 1/20 | 0.82 |
| ▸ | TAF1L | Q8IZX4 | 1/20 | 0.82 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.82 |
| ▸ | KAT2A | Q92830 | 1/20 | 0.82 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.82 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18584911 | 0.92 | BRD4 (1.00) | BRD4TRIM24BRD1CCL2TAF1 | |
| SCHEMBL20493953 | 0.91 | BRD4 (0.81) | BRD4TRIM24BRD1CCL2TAF1 | |
| Gsk620 SCHEMBL18584671 | 0.90 | BRD4 (1.00) | BRD4TRIM24BRD1CCL2TAF1 | |
| SCHEMBL23318383 | 0.90 | BRD4 (0.83) | BRD4TRIM24BRD1CCL2TAF1 | |
| SCHEMBL18617026 | 0.86 | BRD4 (0.92) | BRD4TRIM24BRD1CCL2TAF1 | |
| SCHEMBL20494041 | 0.86 | BRD4 (0.92) | BRD4TRIM24BRD1CCL2TAF1 | |
| SCHEMBL23318232 | 0.86 | BRD4 (0.77) | BRD4TRIM24BRD1CCL2TAF1 | |
| SCHEMBL18616175 | 0.85 | BRD4 (0.90) | BRD4TRIM24BRD1CCL2TAF1 | |
| SCHEMBL24311756 | 0.85 | BRD4 (0.69) | BRD4TRIM24BRD1CCL2TAF1 | |
| SCHEMBL20494176 | 0.85 | BRD4 (0.85) | BRD4TRIM24BRD1CCL2TAF1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10428026-B2 | Pyridinone dicarboxamide for use as bromodomain inhibitors | GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) | 2019-10-01 | — | — | US | claimed |
| US-20180258044-A1 | PYRIDINONE DICARBOXAMIDE FOR USE AS BROMODOMAIN INHIBITORS | GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) | 2018-09-13 | — | — | US | claimed |
| CN-108137542-B | Pyridone dicarboxamides as bromodomain inhibitors | 葛兰素史克知识产权第二有限公司 | 2023-10-27 | — | — | CN | disclosed |
| US-10927080-B2 | Pyridinone dicarboxamide for use as bromodomain inhibitors | GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) | 2021-02-23 | — | — | US | disclosed |
| US-10927080-B2 | Pyridinone dicarboxamide for use as bromodomain inhibitors | GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) | 2021-02-23 | — | — | US | disclosed |
| US-10428026-B2 | Pyridinone dicarboxamide for use as bromodomain inhibitors | GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) | 2019-10-01 | — | — | US | disclosed |
| US-10428026-B2 | Pyridinone dicarboxamide for use as bromodomain inhibitors | GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) | 2019-10-01 | — | — | US | disclosed |
| US-20180258044-A1 | PYRIDINONE DICARBOXAMIDE FOR USE AS BROMODOMAIN INHIBITORS | GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) | 2018-09-13 | — | — | US | disclosed |
| EP-3344615-A1 | PYRIDINONE DICARBOXAMIDE FOR USE AS BROMODOMAIN INHIBITORS | GlaxoSmithKline Intellectual Property (No. 2) Limited (GB) | 2018-07-11 | — | — | EP | disclosed |
| CN-108137542-A | Pyridone diformamide as bromine structural domain inhibitor | 葛兰素史克知识产权第二有限公司 | 2018-06-08 | — | — | CN | disclosed |
| WO-2017037116-A1 | PYRIDINONE DICARBOXAMIDE FOR USE AS BROMODOMAIN INHIBITORS | GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) | 2017-03-09 | — | — | WO | disclosed |
| WO-2017037116-A1 | PYRIDINONE DICARBOXAMIDE FOR USE AS BROMODOMAIN INHIBITORS | GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) | 2017-03-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10428026-B2 | Pyridinone dicarboxamide for use as bromodomain inhibitors | BRD4, BRD3, BRDT | BRD4 1/4885TRIM24 3023/4885BRD1 6/4885 |
| US-20180258044-A1 | PYRIDINONE DICARBOXAMIDE FOR USE AS BROMODOMAIN INHIBITORS | BRD4, BRD3, BRDT | BRD4 1/4885TRIM24 3023/4885BRD1 6/4885 |
| US-10927080-B2 | Pyridinone dicarboxamide for use as bromodomain inhibitors | BRD4, BRD3, BRDT | BRD4 1/4885TRIM24 3023/4885BRD1 6/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.